Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT05566782
Active, not recruiting Observational

Cross-sectoral Rehabilitation After Stroke (CRES)

NCT05566782 · tracked via the Priya Life Science Denmark tracker
Sponsor
Nordsjaellands Hospital
Phase
Observational
Started
2022-01-23
Last updated
2024-11-15

Condition(s) studied

StrokeNeurological RehabilitationPatient Involvement

Study summary

Prospective cohort study during post stroke rehabilitation in hospital and municipality. Participants will be measured with accelerometers, tests in relation to physical function and qualitative interviews.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 18 years of age; * Hospitalized at Nordsjællands Hospital (NOH) with acute stroke; * Discharged from the Department of Neurology NOH with a general rehabilitation plan to one of the eight surrounding municipalities (Hillerød, Allerød, Gribskov, Helsingør, Hørsholm, Halsnæs, Frederikssund Fredensborg); * able to give written informed consent; Exclusion Criteria: * Poor Danish language skill; * Patients refusing any rehabilitation or medically assessed as inevitably dying within 12 weeks;

Primary outcome measure(s)

  • Physical activity measured by step counts and intensity minutes during the day (raw acceleration per time cycle) — 10-14 days from hospital discharge til start of rehabilitation in municipality
    3D Accelerometers able to capture the daily physical activity performed by the participants in terms of intensity minutes and daily step counts (physiological parameter)
  • Change in physical function (30 second chair stand test) — At four timepoints during rehabilitation. Anticipated days for testing: day 1, day 4, day 11, day 95
    Tests performed during in hospital stay and at discharge and at start/end of rehabilitation
  • Change in balance (Bergs Balance Scale) — At four timepoints during rehabilitation. Anticipated days for testing: day 1, day 4, day 11, day 95
    Tests performed during in hospital stay and at discharge and at start/end of rehabilitation in municipality. Scores registered in ordinal scale from 0-56 with higher scores indicating lower risk of fall. Bergs Balance Scale consists of 14 test items each with scores ranging from 0, 1, 2, 3 and 4.
  • Change in Health Related Quality of Life (EQ5D-5L) — Measurement at the start of rehabilitation (day 1) and at the anticipated end of rehabilitation (day 95)
    Measurements with EQ5D-5L send electronically to participants with REDcap system

Trial sites (1)

FacilityCityRegionStatus
Nordsjællands Hospital Department of Neurology Hillerød Denmark

More Nordsjaellands Hospital trials in Denmark

Surviving Pneumonia Recruiting
Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers Recruiting
Impact of Physical Exercise at a Hospital Recruiting
Ultrasound-guided Peripheral Nerve Blocks - a Database Recruiting
Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway Recruiting

Other trials for the same condition

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress Recruiting
Video Call Assisted Assessment of Acute Stroke Recruiting
COMPuter-assisted Self-training to Improve EXecutive Function Active, not recruiting
Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion Active, not recruiting
Robot-Assisted Training Versus Standard Training in Ischemic Stroke Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05566782 on ClinicalTrials.gov ↗ ← All trials in Denmark